175 related articles for article (PubMed ID: 14999675)
1. Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trials.
Caldwell SH; Chang C; Macik BG
Hepatology; 2004 Mar; 39(3):592-8. PubMed ID: 14999675
[TBL] [Abstract][Full Text] [Related]
2. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
Murkin JM
Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
[TBL] [Abstract][Full Text] [Related]
3. Recombinant factor VIIa in the treatment of bleeding.
Midathada MV; Mehta P; Waner M; Fink LM
Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
[TBL] [Abstract][Full Text] [Related]
4. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy.
Shami VM; Caldwell SH; Hespenheide EE; Arseneau KO; Bickston SJ; Macik BG
Liver Transpl; 2003 Feb; 9(2):138-43. PubMed ID: 12548507
[TBL] [Abstract][Full Text] [Related]
5. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
[TBL] [Abstract][Full Text] [Related]
6. The use of recombinant factor VIIa in liver diseases.
Franchini M; Montagnana M; Targher G; Zaffanello M; Lippi G
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):341-8. PubMed ID: 18600080
[TBL] [Abstract][Full Text] [Related]
7. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
Fischer D; Schloesser R; Buxmann H; Veldman A
J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
[TBL] [Abstract][Full Text] [Related]
8. Hematologic disorders in critically ill patients.
Mercer KW; Gail Macik B; Williams ME
Semin Respir Crit Care Med; 2006 Jun; 27(3):286-96. PubMed ID: 16791761
[TBL] [Abstract][Full Text] [Related]
9. The emerging role of recombinant-activated factor VII in neurocritical care.
Fewel ME; Park P
Neurocrit Care; 2004; 1(1):19-29. PubMed ID: 16174895
[TBL] [Abstract][Full Text] [Related]
10. Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review.
Franchini M; Manzato F; Salvagno GL; Lippi G
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):589-93. PubMed ID: 17890943
[TBL] [Abstract][Full Text] [Related]
11. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
12. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
13. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
[TBL] [Abstract][Full Text] [Related]
14. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
[TBL] [Abstract][Full Text] [Related]
15. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
16. "Off-license" use of recombinant activated factor VII.
Ghorashian S; Hunt BJ
Blood Rev; 2004 Dec; 18(4):245-59. PubMed ID: 15501553
[TBL] [Abstract][Full Text] [Related]
17. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
Bhaskar B; Zeigenfuss M; Choudhary J; Fraser JF
Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
[TBL] [Abstract][Full Text] [Related]
18. The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
Udy A; Vaghela M; Lawton G; Sigston P
Anaesthesia; 2005 Jun; 60(6):613-6. PubMed ID: 15918835
[TBL] [Abstract][Full Text] [Related]
19. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
Brady KM; Easley RB; Tobias JD
Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
[TBL] [Abstract][Full Text] [Related]
20. Emerging off-label uses for recombinant activated factor VII: grading the evidence.
Enomoto TM; Thorborg P
Crit Care Clin; 2005 Jul; 21(3):611-32. PubMed ID: 15992675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
